Cancer Biosimilars: Falling Prices, Rising Margins Frederik Joelving March 25, 2026

https://www.medscape.com/viewarticle/cancer-biosimilars-falling-prices-rising-margins-2026a100092n In the US, hospital acquisition prices for oncology biosimilars have dropped faster than reimbursement prices from insurers, leading to an increase in hospital margins, new findings showed.